FDA Inspection 1323800 — Stanford Blood Center LLC
The FDA completed an inspection of Stanford Blood Center LLC on June 17, 2026 in Campbell, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 17, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Campbell, CA (United States)